UKBizDB.co.uk

DESPINA PHARMA LTD

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Despina Pharma Ltd. The company was founded 15 years ago and was given the registration number 07099153. The firm's registered office is in EGHAM. You can find them at Gladstone House, 77-79 High Street, Egham, . This company's SIC code is 46460 - Wholesale of pharmaceutical goods.

Company Information

Name:DESPINA PHARMA LTD
Company Number:07099153
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:09 December 2009
End of financial year:31 December 2022
Jurisdiction:England - Wales
Industry Codes:
  • 46460 - Wholesale of pharmaceutical goods

Office Address & Contact

Registered Address:Gladstone House, 77-79 High Street, Egham, England, TW20 9HY
Country Origin:ENGLAND
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
Gladstone House, 77-79 High Street, Egham, United Kingdom, TW20 9HY

Director10 April 2014Active
Gladstone House, 77-79 High Street, Egham, United Kingdom, TW20 9HY

Secretary30 November 2016Active
Gladstone House, 77 - 79 High Street, Egham, United Kingdom, TW20 9HY

Director09 December 2009Active

People with Significant Control

Mr Sarvesh Bhargava
Notified on:06 April 2016
Status:Active
Date of birth:May 1962
Nationality:Indian
Country of residence:United Kingdom
Address:Gladstone House, 77-79 High Street, Egham, United Kingdom, TW20 9HY
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent
  • Right to appoint and remove directors

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (3 months remaining)

Copyright © 2025. All rights reserved.